CellCept® reaches positive results in Phase III trial in Lupus Nephritis
Vifor Pharma, the pharma business sector of the Galenica Group, and Roche (SIX: RO, ROG;OTCQX: RHHBY), today announced t…
Vifor Pharma, the pharma business sector of the Galenica Group, and Roche (SIX: RO, ROG;OTCQX: RHHBY), today announced t…